Skip to main navigation Skip to search Skip to main content

Daewoong Pharmaceutical's UDCA Lowers Gallstone Risk After Gastric Cancer Surgery by 67%... '1 Year of Use Prevents 6 Years and 8 Months'

Press/Media

Period2026.03.26

Media coverage

1

Media coverage

  • TitleDaewoong Pharmaceutical's UDCA Lowers Gallstone Risk After Gastric Cancer Surgery by 67%... '1 Year of Use Prevents 6 Years and 8 Months'
    Media name/outletContify Life Science News
    Country/TerritoryIndia
    Date26.03.26
    PersonsJaewoo Lee
View all 1
View less